ZA981609B - Method of treating a tumor - Google Patents

Method of treating a tumor

Info

Publication number
ZA981609B
ZA981609B ZA981609A ZA981609A ZA981609B ZA 981609 B ZA981609 B ZA 981609B ZA 981609 A ZA981609 A ZA 981609A ZA 981609 A ZA981609 A ZA 981609A ZA 981609 B ZA981609 B ZA 981609B
Authority
ZA
South Africa
Prior art keywords
mammal
administering
effective amount
tumor
treating
Prior art date
Application number
ZA981609A
Other languages
English (en)
Inventor
Daniel L Dexter
Paul E Juniewicz
James B Rake
Daniel D Van Hoff
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of ZA981609B publication Critical patent/ZA981609B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA981609A 1997-03-07 1998-02-26 Method of treating a tumor ZA981609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81476997A 1997-03-07 1997-03-07

Publications (1)

Publication Number Publication Date
ZA981609B true ZA981609B (en) 1998-12-08

Family

ID=25215967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981609A ZA981609B (en) 1997-03-07 1998-02-26 Method of treating a tumor

Country Status (15)

Country Link
US (2) US6063780A (de)
EP (1) EP1014990B1 (de)
JP (1) JP2001513110A (de)
AT (1) ATE338553T1 (de)
AU (1) AU6178198A (de)
BR (1) BR9808221A (de)
CA (1) CA2281807C (de)
DE (1) DE69835824T2 (de)
DK (1) DK1014990T3 (de)
ES (1) ES2268764T3 (de)
HR (1) HRP980095A2 (de)
NO (1) NO324974B1 (de)
PT (1) PT1014990E (de)
WO (1) WO1998039009A1 (de)
ZA (1) ZA981609B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014990B1 (de) * 1997-03-07 2006-09-06 Sanofi-Aventis U.S. LLC Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
US6866857B1 (en) 1998-10-14 2005-03-15 Debiopharm S.A. Oxalipatinum preparation packaging
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
RU2252022C2 (ru) * 1999-08-30 2005-05-20 Дебиофарм С.А. Стабильный фармацевтический препарат оксалиплатины для парентерального введения
WO2002047725A2 (fr) 2000-12-12 2002-06-20 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
CA2624707A1 (en) * 2005-10-03 2007-04-12 Genetix Pharmaceuticals, Inc. Method for selectively depleting hypoxic cells
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en) 2007-03-16 2011-09-27 The United States Of America As Represented By The Secretary Of The Army High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
CN104043125B (zh) 2008-04-10 2018-01-12 弗吉尼亚州立邦联大学 诱导肿瘤缺氧以治疗癌症
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (de) * 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Verbindungen tirapazamin und quazinon zur verwendung bei der behandlung von gm2-gangliosidosen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
EP1014990B1 (de) * 1997-03-07 2006-09-06 Sanofi-Aventis U.S. LLC Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin

Also Published As

Publication number Publication date
ATE338553T1 (de) 2006-09-15
HRP980095A2 (en) 1998-12-31
EP1014990A1 (de) 2000-07-05
WO1998039009A1 (en) 1998-09-11
EP1014990A4 (de) 2004-03-24
NO994330D0 (no) 1999-09-06
CA2281807C (en) 2007-10-16
JP2001513110A (ja) 2001-08-28
BR9808221A (pt) 2000-05-16
EP1014990B1 (de) 2006-09-06
US6319923B1 (en) 2001-11-20
US6063780A (en) 2000-05-16
DE69835824T2 (de) 2007-03-29
DK1014990T3 (da) 2006-12-11
NO994330L (no) 1999-10-25
PT1014990E (pt) 2006-11-30
CA2281807A1 (en) 1998-09-11
DE69835824D1 (de) 2006-10-19
NO324974B1 (no) 2008-01-14
ES2268764T3 (es) 2007-03-16
AU6178198A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
ZA981609B (en) Method of treating a tumor
AU747599C (en) Antitumor agents
HU9602937D0 (en) Compositions comprising dna damaging agents and p53
CY2473B1 (en) New phenanthridines.
PT880350E (pt) Tratamento de esclerose multipla
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
BG100510A (bg) Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза
EP0902789A4 (de)
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
WO1998030585A3 (en) Use of pea3 in tumor suppression
ID24184A (id) Obat untuk perawatan disfungsi ereksi
CA2408541A1 (en) Treating eczema and/or psoriasis
AP1896A (en) The method of treating cancer
ATE243522T1 (de) Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ZA9711468B (en) New use of comt inhibitors
WO2000004153A3 (en) Repression of cell transformation with human pea3
ATE200026T1 (de) Behandlung von laminitis
RU94024337A (ru) Антиметастатическое средство
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
BR9807980A (pt) Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання